Close Menu

NEW YORK – A new study suggests that proteogenomic analyses may be able to match HPV-negative head and neck squamous cell carcinoma subtypes to potential treatment approaches.

Head and neck squamous cell carcinoma (HNSCC) affects about 53,000 people a year in the US, and though some targeted therapies like EGFR monoclonal antibody and PD-1 inhibitor treatments have been approved to treat HNSCC, response rates have been modest. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Sponsored by

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

Sponsored by

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.